Daniel Mrak

Medical University of Vienna

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Immunology Immunology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (11)

Lisa Schneider

Medical University of Vienna

AUSTRIA

View details

Venugopal Gudipati

Medical University of Vienna

AUSTRIA

View details

Renate Kain

Medical University of Vienna

AUSTRIA

View details

Stephan Blüml

Medical University of Vienna

AUSTRIA

View details

Thomas Perkmann

Medical University of Vienna

AUSTRIA

View details

Helmuth Haslacher

AUSTRIA

View details

Markus Zeitlinger

Medical University of Vienna

AUSTRIA

View details

Ursula Wiedermann

Medical University of Vienna

AUSTRIA

View details

Elisabeth Simader

Medical University of Vienna

AUSTRIA

View details

Michael Bonelli

Medical University of Vienna

AUSTRIA

View details

Andreas Kerschbaumer

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daniel Mrak

Research Interests

Explore related searches

Contact this professor

Articles (11)

FAPi PET/CT for assessment and visualisation of active myositis-related interstitial lung disease: a prospective observational pilot study

Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases

Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls

Response to SARS-CoV-2 vaccination in systemic autoimmune rheumatic disease depends on immunosuppressive regimen: a matched, prospective cohort study.

Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study

Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiency

Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial

Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trial

Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial

Neuropsychiatric Systemic Lupus Erythematosus: A Remaining Challenge

Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritis.

Collaborators (11)

Lisa Schneider

Venugopal Gudipati

Renate Kain

Stephan Blüml

Thomas Perkmann

Helmuth Haslacher

Markus Zeitlinger

Ursula Wiedermann

Elisabeth Simader

Michael Bonelli

Andreas Kerschbaumer

Make your next move.